176 related articles for article (PubMed ID: 35406630)
21. Construction and Comprehensive Analysis of a Stratification System Based on
Wang L; Zhang W; Yang T; He L; Liao Y; Lu J
Dis Markers; 2021; 2021():6144476. PubMed ID: 34840632
[TBL] [Abstract][Full Text] [Related]
22. GDF11 rapidly increases lipid accumulation in liver cancer cells through ALK5-dependent signaling.
Frohlich J; Mazza T; Sobolewski C; Foti M; Vinciguerra M
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jun; 1866(6):158920. PubMed ID: 33684566
[TBL] [Abstract][Full Text] [Related]
23. Role of Lipogenesis Rewiring in Hepatocellular Carcinoma.
Zhou Y; Tao J; Calvisi DF; Chen X
Semin Liver Dis; 2022 Feb; 42(1):77-86. PubMed ID: 34311471
[TBL] [Abstract][Full Text] [Related]
24. Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma.
Huo J; Wu L; Zang Y; Dong H; Liu X; He F; Zhang X
BMC Cancer; 2021 Jan; 21(1):31. PubMed ID: 33413205
[TBL] [Abstract][Full Text] [Related]
25. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
[TBL] [Abstract][Full Text] [Related]
26. Epithelial-Mesenchymal Transition (EMT) Induced by TGF-β in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism.
Soukupova J; Malfettone A; Bertran E; Hernández-Alvarez MI; Peñuelas-Haro I; Dituri F; Giannelli G; Zorzano A; Fabregat I
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073989
[TBL] [Abstract][Full Text] [Related]
27. Increased FNDC5/Irisin expression in human hepatocellular carcinoma.
Gaggini M; Cabiati M; Del Turco S; Navarra T; De Simone P; Filipponi F; Del Ry S; Gastaldelli A; Basta G
Peptides; 2017 Feb; 88():62-66. PubMed ID: 28012856
[TBL] [Abstract][Full Text] [Related]
28. Integrated analysis of ceRNA network reveals potential prognostic Hint1-related lncRNAs involved in hepatocellular carcinoma progression.
Zhang C; Bao T; Ke Y; Liu X; Wang X; Liao W; He Y; Wang L
World J Surg Oncol; 2022 Mar; 20(1):67. PubMed ID: 35241097
[TBL] [Abstract][Full Text] [Related]
29. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis.
Qiao Y; Yuan F; Wang X; Hu J; Mao Y; Zhao Z
Cancer Biomark; 2022; 35(2):227-243. PubMed ID: 36120772
[TBL] [Abstract][Full Text] [Related]
30. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
[TBL] [Abstract][Full Text] [Related]
31. The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma.
Lewinska M; Santos-Laso A; Arretxe E; Alonso C; Zhuravleva E; Jimenez-Agüero R; Eizaguirre E; Pareja MJ; Romero-Gómez M; Arrese M; Suppli MP; Knop FK; Oversoe SK; Villadsen GE; Decaens T; Carrilho FJ; de Oliveira CP; Sangro B; Macias RIR; Banales JM; Andersen JB
EBioMedicine; 2021 Nov; 73():103661. PubMed ID: 34740106
[TBL] [Abstract][Full Text] [Related]
32. Sortilin-Driven Cancer Secretome Enhances Tumorigenic Properties of Hepatocellular Carcinoma via de Novo Lipogenesis.
Chan KK; Au KY; Suen LH; Leung B; Wong CY; Leow WQ; Lim TK; Ng IO; Chung CY; Lo RC
Am J Pathol; 2023 Dec; 193(12):2156-2171. PubMed ID: 37673328
[TBL] [Abstract][Full Text] [Related]
33. Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma.
Zhan K; Bai Y; Liao S; Chen H; Kuang L; Luo Q; Lv L; Qiu L; Mei Z
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278494
[TBL] [Abstract][Full Text] [Related]
34. MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
Zhao JZ; Wang W; Liu T; Zhang L; Lin DZ; Yao JY; Peng X; Jin G; Ma TT; Gao JB; Huang F; Nie J; Lv Q
BMC Cancer; 2022 Dec; 22(1):1290. PubMed ID: 36494680
[TBL] [Abstract][Full Text] [Related]
35. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
36. The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.
Darpolor MM; Basu SS; Worth A; Nelson DS; Clarke-Katzenberg RH; Glickson JD; Kaplan DE; Blair IA
NMR Biomed; 2014 Apr; 27(4):381-9. PubMed ID: 24497316
[TBL] [Abstract][Full Text] [Related]
37. Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects.
Shang RZ; Qu SB; Wang DS
World J Gastroenterol; 2016 Dec; 22(45):9933-9943. PubMed ID: 28018100
[TBL] [Abstract][Full Text] [Related]
38. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
[TBL] [Abstract][Full Text] [Related]
39. Deregulated GATA6 modulates stem cell-like properties and metabolic phenotype in hepatocellular carcinoma.
Tan HW; Leung CO; Chan KK; Ho DW; Leung MS; Wong CM; Ng IO; Lo RC
Int J Cancer; 2019 Oct; 145(7):1860-1873. PubMed ID: 30834518
[TBL] [Abstract][Full Text] [Related]
40. ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p.
Yu X; Lin Q; Wu Z; Zhang Y; Wang T; Zhao S; Song X; Chen C; Wang Z; Xu L; Li C; Gao L; Liang X; Yue X; Ma C
J Pathol; 2020 Dec; 252(4):358-370. PubMed ID: 32770671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
